UMIN000020255 2016/02/01 観察/Observational

・開始前/Preinitiation

卵管癌の分子生物学的特性の解析 exit_disclaimer.gif

The molecular biologic chracteristic analysis of primary fallopian tube carcinoma exit_disclaimer.gif

・【classification/分類項目】 卵管癌 primary fallopian tube carcinoma

・【classification/分類項目】 東北大学 産婦人科 Department of Gynecology and Obstetrics , Tohoku University

 

UMIN000020648 2016/01/20 治療・ケア/Treatment 手技/Maneuver

・一般募集中/Open public recruiting

BRCA1/2変異陽性邦人女性に対する予防的卵巣卵管切除の有用性の検証 exit_disclaimer.gif

Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriers exit_disclaimer.gif

・【classification/分類項目】 遺伝性乳癌卵巣癌 hereditary breast and ovarian cancer

・【classification/分類項目】 順天堂大学 Juntendo University

 

【Basic Info】 UMIN000019847 2015/11/18 治療・ケア/Treatment 医療器具・機器/Device,equipment

・限定募集中/Enrolling by invitation

低温保存腹水を用いた腹水濾過濃縮再静注法(CART)の有用性の検証 exit_disclaimer.gif

Inspection of the usefulness of the Cell-free and concentrated Ascites Reinfusion Therapy (CART) by the cryopreservation ascites exit_disclaimer.gif

・【classification/分類項目】 卵巣癌卵管癌子宮頚癌子宮体癌、腹膜癌 肝臓癌、肝硬変、肺癌胃癌大腸癌、直腸癌 Ovarian cander, Tubal carcinoma, Cervical cancer, Endometrial cancer, Primary peritoneal cancer, Liver cancer, Liver cirrhosis, Lung cancer, Gastric cancer, Colon cancer, Rectal cancer

・【classification/分類項目】 東京女子医科大学 輸血・細胞プロセシング科 Division of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University

 

【Basic Info】 UMIN000019560 2015/10/29 治療・ケア/Treatment 医薬品/Medicine 遺伝子/Gene

・限定募集中/Enrolling by invitation

標準的な一次治療であるプラチナ製剤/タキサン製剤併用化学療法とベバシズマブ(化学療法との併用及び維持療法)による治療を受けた進行(FIGO IIIB-IV期)高悪性度漿液性又は類内膜卵巣癌、卵管癌又は腹膜癌患者を対象にolaparibをプラセボと比較するランダム化、二重盲検、第III相試験 exit_disclaimer.gif

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB-IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance exit_disclaimer.gif

・【classification】 進行(FIGO IIIB-IV期)高悪性度漿液性又は類内膜卵巣癌卵管癌又は腹膜癌 Advanced FIGO Stage IIIB-IV High Grade Serous or Endometrioid Ovarian,Fallopian Tube, or Peritoneal Cancer

・【classification】 一般社団法人北関東婦人科がん臨床試験コンソーシアム GOTIC

・【classification】 Molecular Targeted Drugs/ 分子標的薬

・一般名/ ベバシズマブ(遺伝子組換え)Bevacizumab(genetical recombination)商品名:アバスチン(AVASTIN) 抗VEGFヒト化モノクロナール抗体